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ABSTRACT: Background: People with Parkinson’s dis-
ease (PD) who develop visuo-perceptual deficits are at higher
risk of dementia, but we lack tests that detect subtle visuo-
perceptual deficits and can be performed by untrained per-
sonnel. Hallucinations are associated with cognitive impair-
ment and typically involve perception of complex objects.
Changes in object perception may therefore be a sensitive
marker of visuo-perceptual deficits in PD.
Objective: We developed an online platform to test
visuo-perceptual function. We hypothesised that (1)
visuo-perceptual deficits in PD could be detected using
online tests, (2) object perception would be preferen-
tially affected, and (3) these deficits would be caused
by changes in perception rather than response bias.
Methods: We assessed 91 people with PD and 275 con-
trols. Performance was compared using classical frequent-
ist statistics. We then fitted a hierarchical Bayesian signal
detection theory model to a subset of tasks.
Results: People with PD were worse than controls at
object recognition, showing no deficits in other visuo-
perceptual tests. Specifically, they were worse at identi-
fying skewed images (P<.0001); at detecting hidden
objects (P5.0039); at identifying objects in peripheral
vision (P<.0001); and at detecting biological motion
(P5.0065). In contrast, people with PD were not worse
at mental rotation or subjective size perception. Using
signal detection modelling, we found this effect was
driven by change in perceptual sensitivity rather than
response bias.
Conclusions: Online tests can detect visuo-perceptual defi-
cits in people with PD, with object recognition particularly
affected. Ultimately, visuo-perceptual tests may be developed
to identify at-risk patients for clinical trials to slow PD demen-
tia. VC 2018 The Authors. Movement Disorders published by
Wiley Periodicals, Inc. on behalf of International Parkinson and
Movement Disorder Society.
Key Words: Parkinson’s disease; vision; perception;
hallucinations; signal detection theory
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Dementia affects up to 50% of people with Parkin-
son’s disease (PD) within 10 years of diagnosis1 with
great societal and financial impacts. Converging evi-
dence shows that PD patients with involvement of
visual processing are at highest risk of PD dementia.2,3
However, current measures of visuo-perceptual func-
tion are poorly sensitive (eg, copying intersecting pen-
tagons4 or clock drawing5 or require trained personnel
and are time consuming to perform (such as the
Vision Object and Space Perception battery6 or Ben-
ton’s Judgment of Line Orientation7,8.
Visual hallucinations affect 40% to 50% of people
with PD9,10 and typically involve perception of com-
plex objects, implicating object processing pathways.10
We reasoned that tests of object recognition would be
most likely to detect deficits in PD. In the healthy
brain, object recognition includes visual search11 and
object invariance.12 It is not well studied in PD, with
reports limited to detection of embedded patterns13
and facial emotion recognition.14
Deficits in visuo-perceptual processing could poten-
tially be caused by bottom-up sensory deficits, or top-
down factors, such as response bias, a tendency to
report signals as present or absent. The framework of
signal detection theory allows us to test which is most
affected in PD. The theory proposes that perceptual
performance is determined by sensitivity of a system
to signal relative to background noise, known as d-
prime (d’), and bias to report signal presence,
described as criterion, c.15 Although criterion shifts
may be driven by changes at either a perceptual or
decisional locus,16 changes in sensitivity are modelled
as changes in signal-to-noise ratio, indicating a selec-
tive effect on perceptual processing.15 Given the
involvement of visual processing in PD, we hypothe-
sized that people with PD would show impaired per-
ceptual sensitivity with relative preservation of
criterion.
We therefore developed an online test of visuo-
perception in PD. We hypothesised that (1) visuo-
perceptual deficits in PD could be detected using
online tests, (2) object perception tasks would be pref-
erentially affected, and (3) differences in performance
would be caused by changes in perception rather than
response bias.
Materials and Methods
Participants
Participants accessed the study in 2 ways: a local
group accessed the website at our study center, and a
web-based group accessed the website independently
(Fig. 1A). Patients in the local group were recruited
from PD clinics at the National Hospital for Neurol-
ogy and Neurosurgery and Royal Free Hospital, Lon-
don, UK. Inclusion criteria were clinically diagnosed
PD (Queen Square Brain Bank criteria, early to mid-
stage disease [Hoehn & Yahr 1-3]). Exclusion criteria
included confounding neurological or psychiatric dis-
orders, eye disease, or dementia. Participants with PD
continued their usual levodopa therapy. Age-matched
controls were recruited from university databases and
unaffected spouses. Participants in the web-based
group were recruited from PD clinics, support groups,
and a national newspaper article. We excluded partici-
pants aged 40 or younger and those with atypical PD
(Fig. 1A). Duplicate attempts were removed (highest-
scoring performance retained). All participants gave
informed consent on an online consent form, with
additional written informed consent for the local
group. The study was approved by the Queen Square
Research Ethics Committee.
Assessment of Local Participants
The severity of symptoms was assessed using the
MDS-UPDRS. Visual acuity was measured using a 6-
m chart and converted to decimal acuity. Contrast
sensitivity was measured using a Pelli-Robson chart
(SSV-281-PC; http://www.sussex-vision.co.uk). Cogni-
tion was assessed using the Mini-Mental State Exami-
nation and Montreal Cognitive Assessment.
Online Assessments
Participants accessed the website (https://vision-in-
parkinsons.co.uk/) using a Dell latitude 3340 laptop
(Dell (Round Rock, Texas, USA)) (local group) or
their own devices. Participants completed a clinical
questionnaire on the website, providing demographic
information and disease status and indicating the pres-
ence or absence of visual hallucinations (Table 1).
To mitigate against screen variation, the tasks were
internally controlled for differences in aspect ratios,
resolutions, and viewing distances. We avoided tasks
dependent on contrast sensitivity requiring screen
gamma correction. Attempts to participate using a
mobile phone were redirected to a larger monitor.
Images were rescaled according to screen resolution
and monitor size with participant-inputted informa-
tion to calculate mm/pixel. The online tests took
approximately 45 minutes and were generally well
received by participants.
Tests of Visuo-Perceptual Function
The participants underwent practice sessions prior
to each task. A fixation cross between trials (0.758
visual angle, 1500 milliseconds) encouraged central
fixation. Short presentation times prevented eye move-
ment confounds.
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FIG. 1. (A) Patient recruitment and inclusion in the study, showing the number of patients and controls in each online task. (B) Online visuo-
perceptual tasks: Object invariance. Example skewed image. A dog is shown here. On each trial, an image of a cat or dog was shown for 280
milliseconds. Participants were then shown a choice screen, where they reported whether they had seen a cat or a dog using the computer mouse
(3000 milliseconds response time, 24 trials). Hidden figures. The image contains 22 horses, 7 of which are not hidden, the rest are formed within
the background features. Participants used their computer mouse to click on all the horses they could find. A maximum of 6 minutes and 75 clicks
was allowed to reduce “blind” clicking across the entire image. Image produced by Steven M. Gardner and used here with permission. Peripheral
object detection. Two images of animals were shown: one at fixation the other in the periphery. Presentation time was 280 milliseconds, followed
by a choice screen where participants indicated whether the 2 presented animals were the same or different in identity. The image at fixation was
smaller to enforce central fixation (24 trials). Biological motion. Participants were shown a moving point-light walker, either with dots at the position
of the major joints of a person moving, or with the position of the dots scrambled so that no percept of a person is formed. Participants indicated
whether they had seen a person or scrambled moving dots (3000 milliseconds response time, 24 trials). Subjective size perception. In the classical
form of the Ebbinghaus illusion, 2 identical circles are surrounded by smaller or larger inducers. This causes a perceived difference in the size of the
central circles. Here, we modified this illusion by surrounding the larger inducing circles by 8 test circles that were each surrounded by 12 inducers.
One of the test circles matched the central target circle in diameter. The others differed by a pseudorandom amount, drawn from a normal distribu-
tion around the diameter of the reference circle. The position of the identical test circle differed on each trial. Participants selected the test circle
that matched the central circle in size using the computer mouse (15 trials). Mental rotation. Participants selected the grid in the lower row that
matched the grid in the top row, but rotated (24 trials).
Object Recognition Tests (Fig. 1B)
1. Object Invariance
This probes ability to recognise objects at extreme
angles and may be linked with infero-temporal cortex
activity.17 We recently showed18 that this process is
impaired in PD. Whether deficits can be detected using
a short online test is not known.
Stimuli were prepared using MATLAB 2014a
(https://uk.mathworks.com/).18 A total of 50 images
(25 cats, 25 dogs) from an open online database (www.
kaggle.com) were converted to grayscale and Fourier
transformed. The phase matrix of each image was com-
bined with white noise and the average magnitude
matrix of the whole stimulus set using an inverse Fou-
rier transform.19 The resulting image was sheared using
an affine matrix transformation (3 levels of skew: 0,
1.4, and 2.3 arbitrary units, order pseudorandomized).
The images were scaled relative to screen width and
subtended 483138. On each trial the skewed image
was presented centrally for 450 milliseconds followed
by a choice screen (3000 milliseconds, 24 trials). Partici-
pants scoring 50% at the lowest difficulty level were
excluded (PD, n5 2; controls, n52).
2. Hidden Figures
Misperception of objects in PD10 may be caused by
top-down processes, where patients are primed to see
objects more readily, or to impaired object detection.
We tested these 2 competing theories using object
detection within a complex scene.11
The stimulus was an image depicting 22 horses (SM
Gardner, with permission [http://www.gardnergallery.
com/], 7 horses not hidden, remainder formed within
surrounding scenery; Fig. 1B). Image size 1383 178
(scaled to screen height). The participants clicked on
every horse they found (maximum 75 clicks, 6
minutes). Total number of horses found, repeat selec-
tions, incorrect selection of nonhorse areas, and total
time were recorded.
3. Peripheral Object Recognition
People with PD show reduced contrast sensitivity in
the periphery.20 We used a matching task to test
peripheral object detection.
Images of a cat, dog, or mouse were shown in pairs
(1 central, 1 at 81% screen width, side pseudor-
andomized, 450 milliseconds, followed by choice
screen, 24 trials; Fig. 1B). Image identity was either
matched or different. To enforce central fixation, the
images were unequal in size (central image height
2.58, peripheral image height 7.58).
4. Biological Motion
Displaying a dot at the position of joints of a mov-
ing person evokes the perception of a person mov-
ing.21 Neuroimaging implicates superior temporal
sulcus22 in this percept. Biological motion perception
TABLE 1. Demographics of participants across all tasks
Demographics of all participants
Clinical characteristics Patients Controls t / or v2 (df) P
N 91 275 NA NA
Male/female 54/37 68/207 36.9 (1) <.0001
Age, y, (SD), (range) 66.0 (8.8), (41-88) 61.7 (9.5), (41-85) 4.0 (164) .00010
Disease duration, y (SD) 4.85 (3.89) NA NA NA
N with hallucinations/without 15 /76 0/275 NA NA
Demographics of local patients
N 31 23 NA NA
Male/female 18/13 10/13 1.13 (1) .29
Age (years) (SD), (range) 66.9 (7.3), (49-80) 67.3 (10.7), (41-80) 20.15 (36.9) .88
Disease duration (years) (SD) 4.9 (3.8) NA NA NA
N with hallucinations/without 5/26 0/23 NA NA
MoCA 27.2 (2.8) (n 5 30) 28.1 (2.0), (n 5 22) 21.3 (50.0) .19
MMSE 29.2 (1.0) (n 5 28) 29.5 (0.59) 21.3 (44.3) .19
Snellen visual acuity 0.99 (0.26) 0.97 (0.28) 0.23 (43.3) .82
Contrast sensitivity 1.76 (0.19) (n 5 20) 1.78 (0.16) (n 5 14) 20.26 (30.7) .80
MDS-UPDRS 1 8.74 (5.4) 2.0 (2.4) 6.2 (43) <.0001
MDS-UPDRS 2 9.10 (4.6) 0.3 (0.7) 10.4 (31.9) <.0001
MDS-UPDRS 3 20.5 (9.0) 3.4 (5.0) 8.8 (48.7) <.0001
MDS-UPDRS 4 1.16 (2.8) 0 (0) 2.3 (30) .026
MDS-UPDRS total 39.6 (16.5) 5.9 (5.8) 10.5 (39.8) <.0001
Hoehn & Yahr 1.47 (0.63) NA NA NA
All participants tested, unless stated otherwise. MMSE, mini-mental state examination; MoCA, Montreal Cognitive Assessment; SD, standard deviation; NA,
not applicable; MDS-UPDRS, Movement Disorder Society Unified Parkinson’s Disease Rating Scale; 1 5 nonmotor symptoms; 2 5 motor symptoms; 3 5
objective motor score; 4 5 motor complications.
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may be affected in PD.23 Whether this can be detected
using online tests is not known.
Stimuli were point-light walkers (12 blue dots on a
white background24. Motion-matched noise dots (0,
10, or 30) were added, providing 3 levels of difficulty.
Control gifs were generated using the point-light
walkers, with dot position and motion scrambled. Fig-
ure height subtended 58.
On each trial a point-light walker or scrambled
motion was selected pseudorandomly (displayed for 2
cycles, 3000 milliseconds, followed by choice screen,
24 trials). Participants scoring50% at lowest diffi-
culty level were excluded (PD, n5 23; controls,
n5 68).
Other Visuo-Perceptual Tests
1. Subjective Size Perception
A central circle surrounded by smaller circles
appears larger than an identically sized circle sur-
rounded by larger circles.25 Behavioral and neuroim-
aging studies suggest that this is mediated by the
primary visual cortex (V1).26 We hypothesized that if
pathological processes associated with PD involve V1,
the magnitude of this illusion might be reduced, and
patients would perform better than controls at this
task.
The stimulus was adapted from the classic illusion
to maximise comparisons with fewer trials. A central
small circle (the “target,” diameter 20 px, 0.58), was
surrounded by 4 large inducers (diameter 90 px,
22.58). This was surrounded by 8 peripheral “test”
circles, with varying diameter, each surrounded by 12
small inducers (diameter 6 px, 1.58; Fig. 1B). On every
trial, 1 of the 8 test circles was identical in diameter
to the target circle (with varying position). The diame-
ter of the 7 test circles varied pseudorandomly in a
log-normal distribution around the exact diameter of
the target circle.
Participants selected the test circle matching the cen-
tral target circle (15 trials). The ratio of test circle to
target circle indicated the magnitude of illusion for
that participant. Geometric mean ratio of selected
circles was calculated and transformed back into log
space.
2. Mental Rotation
This is the ability to match rotated objects and may
involve mid-level visual processing regions such as
V3.27 PD patients carrying microtubule associated
protein tau (MAPT) polymorphisms show deficits in
this process.28 Whether deficits can be seen in PD in
general is not known.
Stimuli consisted of a reference 535 grid, above 3
test grids. Within the reference grid were 4 blue circles
(pseudorandom positions). Test grids were rotated
6908 or6 1808. In 2 test grids, a blue circle was
moved to an adjacent position. Participants selected
the grid that was identical to the reference grid, but
rotated (24 trials).
Online Estimate of Visual Acuity
A Taylor’s-E optotype was presented, surrounded
on 4 sides by outward-pointing triangles (Supplemen-
tal Fig. 1). The participants clicked the triangle beside
the open side of the “E.” The size of the next opto-
type was determined using an adaptive staircase con-
verging onto the participant’s acuity (step sizes 0.05
acuity, 20 steps).29 Visual acuity was calculated as
mean of the last 4 trials.
Tapping Test
An online tapping test (based on the BRAIN test,30
validated for assessment of bradykinesia in PD)
assessed bradykinesia as objective support of PD diag-
nosis. This is a keyboard-tapping task based on alter-
nate finger-tapping between 2 computer keys spaced
15-cm apart. It reliably differentiates between individ-
uals with PD and controls. Participants used the index
finger of 1 hand to press the “S” and “;” keys for 30
seconds, for each hand. The number of key taps in 30
seconds was recorded. Scores less than 10 and 100
were excluded.30 The average score for both hands
was calculated.
Statistical Analysis
Performance was compared between groups using 2-
tailed Welch’s t tests, Mann–Whitney tests for nonnor-
mally distributed data, or repeated measures analyses
of variance (where tasks had more than 1 difficulty
level). We accounted for confounding influences of age
by adjusting for age and separately examining differ-
ences between groups when the oldest PD patients
were removed until the groups were age matched.
We used linear regression to examine effects of fac-
tors on task performance. We then accounted for dif-
ferences in age and gender by including these variables
as covariates in additional regression models for effect
of PD on task performance. Where tasks included
more than 1 difficulty level, the most discriminatory
level was used, defined as greatest effect size, followed
by highest significance level. P< .05, Bonferroni cor-
rected for multiple comparisons (n56 comparisons,
significance< .0083), was accepted as the threshold of
statistical significance. Statistical analysis was per-
formed using R (https://www.r-project.org/).
Signal Detection Analysis
To assess whether perceptual deficits in PD are
reflected either by changes in perception and/or a bias
in decisions and reporting, we used the signal
W E I L E T A L
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detection theory framework. Robust estimation of
parameters of the signal detection model typically
requires large numbers of trials per participant, which
would not be feasible using an online testing system.
Hierarchical models allow robust estimates of group-
level parameters in cases with large samples, but few
trials per participant, as here. Unlike fixed-effects
models that collapse data across participants, a hierar-
chical Bayesian approach is the correct way to com-
bine information about within- and between-subject
uncertainty, such that group-level parameters are less
influenced by single-subject fits that have high degree
of uncertainty. In turn, hierarchical modelling mutu-
ally constrains subject-level parameter estimation
because of the shared dependence on group-level
parameters.31
We fit the hierarchical Bayesian signal detection the-
ory model to tasks that employed a 2-alternative-
forced-choice design. Responses were sorted into hits,
false alarms, misses, and correct rejections. For each
participant, detection sensitivity (d’) and criterion (c)
were calculated separately:
d0 5 zðHÞ–zðFAÞ
c5 20:5 x

zðHÞ 1zðFAÞ

where z indicates inverse of the cumulative normal
distribution, H hit rate, and FA false alarm rate. We
additionally fitted a hierarchical Bayesian signal detec-
tion model32 to obtain posterior distributions of
group-level sensitivity (d’) and bias (c) parameters. We
used Markov Chain Monte Carlo using Gibbs sam-
pling implemented in JAGS (Just Another Gibbs Sam-
pler) in R33 to draw samples from the posterior
distributions. We used uninformative (high variance)
prior distributions on the group-level estimates of d0
and criterion when fitting calibration data (after JAGS
convention, variances are written as precisions, or the
reciprocal of the variance, denoted as k):
ld0  Nð0; 0:001Þ
lc  Nð0; 0:001Þ
kd0  Gammað0:001; 0:001Þ
kc  Gammað0:001; 0:001Þ
d0  Nðld0 ; kd0 Þ
c  Nðlc; kcÞ
Here, N() refers to a standard normal distribution
with given mean and precision; k() refers to a gamma
distribution parameterized by shape and rate parame-
ters. ld0 and lc are group means for d’ and criterion,
respectively.
JAGS was called with 2000 adaptation steps, 5000
burn-in samples, and 50,000 effective samples; 3 chains
for each parameter were run. Convergence of chains
was assessed visually and using the potential scale-
reduction statistic R^. For each task, we fitted the model
twice, once for PD patients, once for controls. Posterior
distributions for each group-level parameter returned
by JAGS, in each participant group, were employed for
Bayesian inference.34 To assess differences between
controls and people with PD we calculated the proba-
bility that the difference between the 2 parameters was
larger than zero, Pu(ld0; controls - ld0; Parkinson0s >0), where
high probability indicates strong evidence in favor of a
difference. We denote these probabilities as Pu to distin-
guish them from classic P values.
Results
Demographics
A total of 428 participants accessed the website
across the 2 groups. We excluded 62 participants
based on exclusion criteria of age, screen width, and
atypical PD (Fig. 1A). The remainder were 91 partici-
pants with PD and 275 controls, with slight variation
in participant numbers in each task (Fig. 1A). Mean
age PD5 66.06 8.8 years; controls5 61.76 9.5 years,
average disease duration54.8563.89 years (Table
1). Of the participants, 15 reported visual hallucina-
tions. In the local group there was no difference in
cognition, visual acuity, or contrast sensitivity between
people with PD and controls (Table 1). Although we
did not directly assess web-based participants, there
were no differences in demographic details or in
visuo-perceptual tests between patients in local and
web-based groups (Supplemental Tables 1 and 2).
Performance in Object Recognition Tests
People with PD were worse at all tasks involving
object recognition. They were worse at object invariance
(main effect PD: F1,3275 24.8, P< .0001; main effect
difficulty: F2,6545433, P< .0001). The interaction
between presence of PD and difficulty tended to signifi-
cance at a Bonferroni-corrected level: F2,65454.1,
P5 .017 (Fig. 2A, Table 2).
People with PD found fewer horses; mean
PD514.663.8; controls5 16.16 3.9, t1365 -2.9,
P5 .0039 (Fig. 2B, Table 2). There was no difference
in the repeat selection of horses, in the selection of
nontarget regions (pareidolia), or total time between
the groups (Table 2).
PD patients were worse at recognizing animals in
peripheral vision than controls (mean PD5 0.696 0.19,
controls50.7960.14, P< .0001; Fig. 2C) and worse at
detecting biological motion (main effect PD: F1,25057.5,
P5 .0065; main effect difficulty: F2,5005 128,
P< .0001; Fig. 2D). There was no interaction between
presence of PD and difficulty (F2,50050.046, P5 .96;
Table 2).
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Performance in Other Visuo-Perceptual Tests
We found no difference in subjective size perception
or mental rotation in PD when compared with con-
trols (Table 2).
Effects of Other Factors on Performance
Performance in object invariance and peripheral
object recognition was worse with age, but when
adjusted for, we continued to see an effect of PD (Sup-
plemental Table 3). Hidden figures performance was
also worse with age, but the effects of PD were no
longer significant when adjusted for age. There was no
effect of age on biological motion, subjective size per-
ception, or mental rotation.
Object invariance and peripheral object recognition
was worse in the men than in the women, especially
in people with PD. When we adjusted for gender, we
continued to see a strong effect of PD.
In biological motion, female controls tended to per-
form worse than male controls, an effect not seen in
PD. When we examined the overall relationship
between gender and performance, no significant rela-
tionship was seen. Performance in hidden figures
tended to be worse in men (with and without PD),
and the effect of PD was no longer significant when
adjusted for gender. The men also showed a slightly
lower effect for subjective size perception. There was
no effect of gender on mental rotation (Supplemental
Table 3).
We found no relationship between visuo-perceptual
performance and disease duration or presence of hal-
lucinations (Supplemental Tables 4 and 5).
There was no relationship between performance in
visuo-perceptual tasks and visual acuity, with the
exception of object invariance, which showed a trend
(that disappeared when adjusted for age) and periph-
eral object recognition (Supplemental Table 4). Effects
of PD on peripheral object recognition persisted when
adjusted for acuity (estimate50.10, standard
error5 0.02, P< .0001), showing differences were not
solely caused by acuity deficits.
Repeat analyses excluding trials with no responses
had no effect on our findings (Supplemental Table 6),
indicating that worse performance was not driven by
higher number of missed trials.
Other Online Measures
The presence of PD trended to correlation with
visual acuity (R250.017, P5 .013), and this was not
significant when adjusted for age (estimate50.0496
0.030), t51.7, P5 .098).
Mean number of taps was lower in PD when com-
pared with controls (Table 2), providing supportive
evidence that the online group suffered from PD.
FIG. 2. Results. (A) Object invariance. Performance in the object invariance test (identifying skewed animals) at 3 levels of skew for controls (light
gray) and people with PD (dark gray). Main effect Parkinson’s disease group and difficulty, both P<.0001. Error bars are standard error of the mean
in all panels. ** Significant after Bonferroni correction in all panels. (B) Hidden figures. Number of horses found by controls (light gray) and people
with PD (dark gray). (C) Peripheral object detection. Performance in matching animals presented at fixation and in peripheral visual field for controls
(light gray) and people with PD (dark gray). (D) Biological motion. Performance in detecting biological motion at 3 levels of difficulty (additional mov-
ing dots) for controls (light gray) and people with PD (dark gray). Main effect Parkinson’s disease group and difficulty, both P<.0001.
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Hierarchical Modelling of Signal Detection
Theory Parameters
We fit a hierarchical Bayesian signal detection model
to participants’ data in object invariance, peripheral
object recognition, and biological motion tasks. These
tasks all adopted a 2-alternative-forced-choice response,
allowing us to specify false alarms as well as hits. This
enabled us to obtain group-level posterior distributions
of sensitivity (d’) and bias (c) separately for controls
and PD patients. Trials with no responses were
excluded from this analysis (Supplemental Table 7).
This approach revealed significant effects of PD on per-
ceptual sensitivity (d’) in all 3 tasks. Conversely, there
were no group differences in detection criterion, a mea-
sure of general bias in reporting presence or absence of
signal, regardless of sensory input (Fig. 3, Supplemental
Table 8).
Discussion
Our online visuo-perceptual platform detected defi-
cits in people with PD when compared with controls.
This suggests that these or similar tasks could poten-
tially be used for disease stratification to identify
patients with visuo-perpetual deficits.
We show that performance in object recognition,
tested using a variety of tasks, is preferentially affected
in PD, suggesting higher level visual processing defi-
cits. Conversely, subjective size perception, which
involves the earliest stages of cortical visual process-
ing35 and mental rotation, which may involve mid-
level visual processing (eg, V327, were not affected.
Until recently, object recognition has not been well
studied in PD. Studies using measures such as the
Vision Object and Space Perception battery have
shown inconsistent findings.36,37 Recognition of
embedded figures may be affected,13 and emotion rec-
ognition, a specialized form of object recognition, is
impaired.14 We recently showed that object invariance
is affected in PD,18 and deficits in biological motion in
PD have recently been shown.23 Here we take this fur-
ther by demonstrating that object recognition is
affected ahead of other aspects of visuo-perception
and can be detected using online tests.
The involvement of higher level visuo-perceptual
regions is consistent with structural neuroimaging
studies showing atrophy of parieto-occipital and
occipito-temporal regions in PD.38
The signal detection approach allowed us to show
that these visuo-perceptual deficits are caused by dif-
ferences in perceptual sensitivity rather than response
bias. We provide new evidence that people with PD
have lower perceptual sensitivity for object recognition
and that effects are not explained by differences in
response bias.
We found that visuo-perceptual deficits correlated
with age, but not disease duration. This is consistent
with literature showing that cognitive involvement in
PD is more prevalent in older patients rather than a
TABLE 2. Performance in each of the online tasks for participants with Parkinson’s disease and controls
Task n Subsection of task Parkinson’s, mean (SD) Controls, mean (SD) t (degrees of freedom) P
Object invariance
PD: n 5 81
HC: n 5 248
Skew level 1 0.94 (0.1) 0.98 (0.1) W 5 8375a .0012b
Skew level 2 0.64 (0.2) 0.75 (0.2) 24.0 (143) <.0001b
Skew level 3 0.52 (0.2) 0.63 (0.2) 23.9 (142) <.0001b
Hidden Figures
PD: n 5 80
HC: n 5 254
Number horses found 14.6 (3.8) 16.1 (3.9) 22.9 (136) .0039b
Background selected 20.8 (15) 20.3 (15) 0.29 (133) .77
Repeat horses 12.0 (8.9) 11.5 (9.8) 0.44 (144) .66
Total time (s) 216.6 (135) 208.4 (108) 0.49 (112) .62
Peripheral object recognition
PD: n 5 87
HC: n 5 246
Performance 0.69 (0.2) 0.79 (0.1) 24.33 (119) <.0001b
Biological motion
PD: n 5 63
HC: n 5 189
Level 1 0.69 (0.1) 0.73 (0.1) 22.9 (139) .0038b
Level 2 0.70 (0.2) 0.74 (0.2) 21.3 (107) .20
Level 3 0.54 (0.2) 0.57 (0.1) 21.8 (101) .075
Subjective size perception
PD: n 5 84
HC: n5 257
Performance (log ratio) -0.06 (0.03) -0.07 (0.04) 1.86 (165) .064
Mental rotation
PD: n 5 84
HC: n 5 251
Performance 0.84 (0.1) 0.85 (0.1) 21.0 (159) .32
Visual acuity Decimal acuity 0.74 (0.3) 0.82 (0.3) 22.5 (146) .013
Tapping test
PD: n 5 90
HC: n 5 267
Number of taps in 30 seconds 42.2 (15) 52.7 (18) 25.3(187) <.0001b
HC, control; PD, Parkinson’s disease; s, seconds; SD, standard deviation.
aMann–Whitney test performed as data for skew level 1 not normally distributed.
bSignificant after Bonferroni correction.
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function of disease duration.1,39 This may relate to a
synergistic relationship between a-synuclein and Alz-
heimer’s pathology that is more prevalent in older
patients: a-synuclein promotes neurofibrillary tau tan-
gle formation,40 and b-amyloid induces pathological
a-synuclein phosphorylation.41
There are some methodological limitations to this
study. Three tasks required a time-limited response.
However, when we repeated analyses excluding “no
response” trials we continued to show worse perfor-
mance in PD, suggesting differences cannot be purely
attributed to slower responses.
The number of people with hallucinations was rela-
tively small, which may have contributed to the lack
of differences between people with visual hallucina-
tions. The lower prevalence rate of hallucinations here
reflects the earlier disease-stage, community-based
nature of our population when compared with other
studies showing higher prevalence rates.9,10
We detected object-level recognition deficits even in
patients with no known dementia and without visual
hallucinations, suggesting our tests can detect cogni-
tive involvement before people become symptomatic.
Visual hallucinations usually involve animate halluci-
nations. Whether object-recognition deficits are spe-
cific to animate versus inanimate objects needs to be
tested in future studies.
Limited clinical data were collected for people par-
ticipating only using the online platform. We were
therefore unable to determine effects of disease sever-
ity and motor phenotype on visuo-perceptual perfor-
mance. Furthermore, we relied on patients’ reports of
PD diagnosis, although these were supported by scores
on a motor dexterity task. Future work could use a
version of this online task in combination with clinical
data, including formal diagnostic criteria of PD and
medication doses, to directly address this.
We found both age and male gender were associated
with poorer performance on some of the visuo-
perceptual tasks, particularly the hidden figures test,
where these effects persisted when adjusted for the
presence of PD. How these factors interact with the
presence of PD is not yet known and could be specifi-
cally addressed to better understand the progression of
the disease.
All patients were taking their routine medications
which may have influenced performance. We previ-
ously showed that object invariance is not related to
levodopa dose,18 and PET imaging studies suggest
cholinergic rather than dopaminergic metabolism is
more closely related to cognitive function in PD.42
This could be addressed in future work.
Finally, our data include a range of patients with
varying disease duration, age, and phenotype. This
heterogeneity may underlie some variation shown
here. To determine whether performance in visuo-
perceptual tasks has prognostic validity, we need lon-
gitudinal analyses, alongside standard measures of dis-
ease severity and cognitive function and to determine
clinically useful cut-offs using these standard measures
as comparisons. Future studies may examine the sensi-
tivity of these online measures in cohorts at risk of
PD, such as those with rapid eye movement sleep dis-
order or anosmia.
In summary, we show that visuo-perceptual deficits
in PD can be detected with short online tests, that
tasks of object recognition are preferentially affected,
and that perceptual sensitivity deficits, rather than
shifts in response bias, underlie these changes. This
platform could be developed in future as a potential
tool for stratification for patients in the earlier stages
of disease for clinical trials aimed at slowing or pre-
venting dementia in PD.
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